GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
2.62B
Enterprise Value 3
2.41B
Trailing P/E
53.83
Forward P/E 1
41.28
PEG Ratio (5 yr expected) 1
2.03
Price/Sales (ttm)
6.11
Price/Book (mrq)
8.20
Enterprise Value/Revenue 3
5.63
Enterprise Value/EBITDA 6
42.46

Trading Information

Stock Price History

Beta (3Y Monthly) 1.25
52-Week Change 37.41%
S&P500 52-Week Change 37.98%
52 Week High 392.18
52 Week Low 350.77
50-Day Moving Average 371.23
200-Day Moving Average 364.34

Share Statistics

Avg Vol (3 month) 3638.86k
Avg Vol (10 day) 3320.18k
Shares Outstanding 537.55M
Float 24.96M
% Held by Insiders 12.77%
% Held by Institutions 186.93%
Shares Short (Sep 30, 2019) 41.38M
Short Ratio (Sep 30, 2019) 43.38
Short % of Float (Sep 30, 2019) 45.18%
Short % of Shares Outstanding (Sep 30, 2019) 43.71%
Shares Short (prior month Aug 30, 2019) 42.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 11.69%
Operating Margin (ttm)11.13%

Management Effectiveness

Return on Assets (ttm)8.58%
Return on Equity (ttm)18.48%

Income Statement

Revenue (ttm)428.78M
Revenue Per Share (ttm)11.75
Quarterly Revenue Growth (yoy)19.40%
Gross Profit (ttm)269.19M
EBITDA 56.87M
Net Income Avi to Common (ttm)50.12M
Diluted EPS (ttm)1.30
Quarterly Earnings Growth (yoy)92.20%

Balance Sheet

Total Cash (mrq)243.55M
Total Cash Per Share (mrq)6.53
Total Debt (mrq)57.22M
Total Debt/Equity (mrq)18.04
Current Ratio (mrq)5.74
Book Value Per Share (mrq)8.51

Cash Flow Statement

Operating Cash Flow (ttm)89.03M
Levered Free Cash Flow (ttm)53.89M